About this item:

128 Views | 96 Downloads

Author Notes:

Correspondence to Dr Michael E. Davis, Associate Professor of Biomedical Engineering, 1760 Haygood Dr, W200, Atlanta, GA 30322. E-mail michael.davis@bme.emory.edu

U. Agarwal and M.E. Davis designed the research.

U. Agarwal, A. George, S. Bhutani, S. Ghosh-Choudhary, M.E. Brown, Y. Liang, and Y. Mehta performed the research.

M.O. Platt and S. Sahoo contributed to analytic tools.

U. Agarwal, A. George, and M.E. Davis analyzed the data.

U. Agarwal and M.E. Davis wrote the article.

We acknowledge the Children’s Miracle Network gift to Children’s Healthcare of Atlanta, as well as support from Katrina Ceccoli and the Darryl M. Ceccoli Research Fund.

Disclosures: None.

Subjects:

Research Funding:

This work was supported by grant HL124380 from the National Heart, Lung, and Blood Institute to M.E. Davis and M.O. Platt, as well as award T32HL007745.

This study was supported in part by the Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC) and Emory Integrated Genomics Core, which are subsidized by the Emory College of Arts and Sciences and the Emory University School of Medicine and is one of the Emory Integrated Core Facilities.

Additional support was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000454.

The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Cardiac & Cardiovascular Systems
  • Hematology
  • Peripheral Vascular Disease
  • Cardiovascular System & Cardiology
  • cardiac progenitor cells
  • exosome
  • microRNA
  • modeling
  • systems biology
  • LEFT-HEART SYNDROME
  • STEM-CELLS
  • MYOCARDIAL-INFARCTION
  • PROTECTS CARDIOMYOCYTES
  • REPAIR
  • TRIAL
  • REGENERATION
  • HYPERTROPHY
  • ANGIOGENESIS
  • MECHANISMS

Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients

Show all authors Show less authors

Tools:

Journal Title:

Circulation Research

Volume:

Volume 120, Number 4

Publisher:

, Pages 701-+

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Rationale: Studies have demonstrated that exosomes can repair cardiac tissue post-myocardial infarction and recapitulate the benefits of cellular therapy. Objective: We evaluated the role of donor age and hypoxia of human pediatric cardiac progenitor cell (CPC)-derived exosomes in a rat model of ischemia-reperfusion injury. Methods and Results: Human CPCs from the right atrial appendages from children of different ages undergoing cardiac surgery for congenital heart defects were isolated and cultured under hypoxic or normoxic conditions. Exosomes were isolated from the culture-conditioned media and delivered to athymic rats after ischemia-reperfusion injury. Echocardiography at day 3 post-myocardial infarction suggested statistically improved function in neonatal hypoxic and neonatal normoxic groups compared with saline-treated controls. At 28 days post-myocardial infarction, exosomes derived from neonatal normoxia, neonatal hypoxia, infant hypoxia, and child hypoxia significantly improved cardiac function compared with those from saline-treated controls. Staining showed decreased fibrosis and improved angiogenesis in hypoxic groups compared with controls. Finally, using sequencing data, a computational model was generated to link microRNA levels to specific outcomes. Conclusions: CPC exosomes derived from neonates improved cardiac function independent of culture oxygen levels, whereas CPC exosomes from older children were not reparative unless subjected to hypoxic conditions. Cardiac functional improvements were associated with increased angiogenesis, reduced fibrosis, and improved hypertrophy, resulting in improved cardiac function; however, mechanisms for normoxic neonatal CPC exosomes improved function independent of those mechanisms. This is the first study of its kind demonstrating that donor age and oxygen content in the microenvironment significantly alter the efficacy of human CPC-derived exosomes.

Copyright information:

© 2016 American Heart Association, Inc.

Export to EndNote